nach oben

Inflammation

Erschienen in:

07.01.2021 | Review

TRIM Proteins in Inflammation: from Expression to Emerging Regulatory Mechanisms

verfasst von: Luting Yang, Haibin Xia

Erschienen in: Inflammation | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Inflammation is an immune response to exogenous or endogenous insults that helps to maintain the tissue homeostasis under stressful conditions. Depending on the differential types of insults, inflammation is classified into microbial, autoimmune, metabolic, allergic, and physical inflammation. With regard to its involvement in the pathogenesis of most of human diseases, dissecting the key molecules in the regulation of inflammatory process is vital for the prevention and therapeutics of human diseases. Tripartite motif (TRIM) proteins are a versatile family of E3 ligases, which are composed of > 80 distinct members in humans recognized for their roles in antiviral responses. Recently, a large number of studies have shown the regulatory roles of TRIM proteins in mediating the inflammation. Herein in this review, we discuss the aberrations of TRIM proteins in autoimmune and autoinflammatory diseases, with a focus on the regulation of different components of inflammatory process, including inflammasome, NF-κB signaling, type I IFN (interferon) production, and Th1/Th17 cell differentiation. Importantly, elucidation of the mechanism underlying the regulation of inflammation by TRIMs provides insights into the use of TRIMs as therapeutic targets for disease treatment.

Hawiger, J., and J. Zienkiewicz. 2019. Decoding inflammation, its causes, genomic responses, and emerging countermeasures. Scandinavian Journal of Immunology 90: e12812–e12812.PubMedPubMedCentral

Zhang, Y., H. Fan, J. Xu, Y. Xiao, Y. Xu, Y. Li, and X. Li. 2013. Network analysis reveals functional cross-links between disease and inflammation genes. Scientific Reports 3: 3426–3426.PubMedPubMedCentral

Rathinam, V.A., and K.A. Fitzgerald. 2016. Inflammasome Complexes: Emerging Mechanisms and Effector Functions. Cell 165: 792–800.PubMedPubMedCentral

Repa, A., G.K. Bertsias, E. Petraki, C. Choulaki, D. Vassou, K. Kambas, D.T. Boumpas, G. Goulielmos, and P. Sidiropoulos. 2015. Dysregulated production of interleukin-1β upon activation of the NLRP3 inflammasome in patients with familial Mediterranean fever. Human Immunology 76: 488–495.PubMed

Gurung, P., and T.-D. Kanneganti. 2016. Autoinflammatory skin disorders: the inflammasome in focus. Trends in Molecular Medicine 22: 545–564.PubMedPubMedCentral

Labzin, L.I., M. Bottermann, P. Rodriguez-Silvestre, S. Foss, J.T. Andersen, M. Vaysburd, D. Clift, and L.C. James. 2019. Antibody and DNA sensing pathways converge to activate the inflammasome during primary human macrophage infection. The EMBO Journal 38: e101365.PubMedPubMedCentral

Coll, R.C. 2019. Role reversal: adaptive immunity instructs inflammasome activation for anti-viral defence. The EMBO Journal 38: e103533.PubMedPubMedCentral

Mitoma, H., S. Hanabuchi, T. Kim, M. Bao, Z. Zhang, N. Sugimoto, and Y.J. Liu. 2013. The DHX33 RNA helicase senses cytosolic RNA and activates the NLRP3 inflammasome. Immunity 39: 123–135.PubMedPubMedCentral

Weng, L., H. Mitoma, C. Trichot, M. Bao, Y. Liu, Z. Zhang, and Y.J. Liu. 2014. The E3 ubiquitin ligase tripartite motif 33 is essential for cytosolic RNA-induced NLRP3 inflammasome activation. Journal of Immunology 193: 3676–3682.

10.

Hu, Y., K. Mao, Y. Zeng, S. Chen, Z. Tao, C. Yang, S. Sun, X. Wu, G. Meng, and B. Sun. 2010. Tripartite-motif protein 30 negatively regulates NLRP3 inflammasome activation by modulating reactive oxygen species production. Journal of Immunology 185: 7699–7705.

11.

Kimura, T., A. Jain, S.W. Choi, M.A. Mandell, T. Johansen, and V. Deretic. 2017. TRIM-directed selective autophagy regulates immune activation. Autophagy 13: 989–990.PubMed

12.

Aral, K., E. Berdeli, P.R. Cooper, M.R. Milward, Y. Kapila, B. Karadede Ünal, C.A. Aral, and A. Berdeli. 2020. Differential expression of inflammasome regulatory transcripts in periodontal disease. Journal of Periodontology 91: 606–616.PubMed

13.

Stoler, I., J. Freytag, B. Orak, N. Unterwalder, S. Henning, K. Heim, H. von Bernuth, R. Krüger, S. Winkler, P. Eschenhagen, E. Seipelt, M.A. Mall, D. Foell, C. Kessel, H. Wittkowski, and T. Kallinich. 2020. Gene-dose effect of MEFV gain-of-function mutations determines ex vivo neutrophil activation in familial mediterranean fever. Frontiers in Immunology 11: 716–716.PubMedPubMedCentral

14.

Kunishita, Y., R. Yoshimi, R. Kamiyama, D. Kishimoto, K. Yoshida, E. Hashimoto, T. Komiya, N. Sakurai, Y. Sugiyama, Y. Kirino, K. Ozato, and H. Nakajima. 2020. TRIM21 dysfunction enhances aberrant B-cell differentiation in autoimmune pathogenesis. Frontiers in Immunology 11: 98–98.PubMedPubMedCentral

15.

Brauner, S., M. Ivanchenko, G.E. Thorlacius, A. Ambrosi, and M. Wahren-Herlenius. 2018. The Sjögren's syndrome-associated autoantigen Ro52/TRIM21 modulates follicular B cell homeostasis and immunoglobulin production. Clinical and Experimental Immunology 194: 315–326.PubMedPubMedCentral

16.

Yang, L., T. Zhang, C. Zhang, C. Xiao, X. Bai, and G. Wang. 2020. Upregulated E3 ligase Trim21 in psoriatic epidermis ubiquitylates NF-κB p65 subunit and promotes inflammation in keratinocytes. British Journal of Dermatology. https://doi.org/10.1111/bjd.19057.CrossRef

17.

Niida, M., M. Tanaka, and T. Kamitani. 2010. Downregulation of active IKK beta by Ro52-mediated autophagy. Molecular Immunology 47: 2378–2387.PubMedPubMedCentral

18.

Shi, M., H. Cho, K.-S. Inn, A. Yang, Z. Zhao, Q. Liang, G.A. Versteeg, S. Amini-Bavil-Olyaee, L.-Y. Wong, B.V. Zlokovic, H.S. Park, A. García-Sastre, and J.U. Jung. 2014. Negative regulation of NF-κB activity by brain-specific TRIpartite Motif protein 9. Nature Communications 5: 4820–4820.PubMedPubMedCentral

19.

Sun, M., S. Li, K. Yu, J. Xiang, and F. Li. 2019. An E3 ubiquitin ligase TRIM9 is involved in WSSV infection via interaction with beta-TrCP. Developmental and Comparative Immunology 97: 57–63.PubMed

20.

Jang, H.-D., H.Z. Hwang, H.-S. Kim, and S.Y. Lee. 2019. C-Cbl negatively regulates TRAF6-mediated NF-κB activation by promoting K48-linked polyubiquitination of TRAF6. Cellular & Molecular Biology Letters 24: 29–29.

21.

Chang, T.-H., R. Yoshimi, and K. Ozato. 2015. Tripartite motif (TRIM) 12c, a mouse homolog of TRIM5, is a ubiquitin ligase that stimulates type I IFN and NF-κB pathways along with TNFR-associated factor 6. Journal of Immunology (Baltimore, Md. : 1950) 195: 5367–5379.

22.

Zhao, W., L. Wang, M. Zhang, C. Yuan, and C. Gao. 2012. E3 ubiquitin ligase tripartite motif 38 negatively regulates TLR-mediated immune responses by proteasomal degradation of TNF receptor-associated factor 6 in macrophages. Journal of Immunology 188: 2567–2574.

23.

Huang, X., Y. Li, X. Li, D. Fan, H.B. Xin, and M. Fu. 2020. TRIM14 promotes endothelial activation via activating NF-kappaB signaling pathway. Journal of Molecular Cell Biology 12: 176–189.PubMed

24.

Noguchi, K., F. Okumura, N. Takahashi, A. Kataoka, T. Kamiyama, S. Todo, and S. Hatakeyama. 2011. TRIM40 promotes neddylation of IKKgamma and is downregulated in gastrointestinal cancers. Carcinogenesis 32: 995–1004.PubMed

25.

Qiu, H., F. Huang, H. Xiao, B. Sun, and R. Yang. 2013. TRIM22 inhibits the TRAF6-stimulated NF-kappaB pathway by targeting TAB2 for degradation. Virologica Sinica 28: 209–215.PubMed

26.

Shi, M., W. Deng, E. Bi, K. Mao, Y. Ji, G. Lin, X. Wu, Z. Tao, Z. Li, X. Cai, S. Sun, C. Xiang, and B. Sun. 2008. TRIM30α negatively regulates TLR-mediated NF-κB activation by targeting TAB2 and TAB3 for degradation. Nature Immunology 9: 369–377.PubMed

27.

Matsuda, A., Y. Suzuki, G. Honda, S. Muramatsu, O. Matsuzaki, Y. Nagano, T. Doi, K. Shimotohno, T. Harada, E. Nishida, H. Hayashi, and S. Sugano. 2003. Large-scale identification and characterization of human genes that activate NF-κB and MAPK signaling pathways. Oncogene 22: 3307–3318.PubMed

28.

Kim, K., J.H. Kim, I. Kim, S. Seong, and N. Kim. 2018. TRIM38 regulates NF-kappaB activation through TAB2 degradation in osteoclast and osteoblast differentiation. Bone 113: 17–28.PubMed

29.

Hu, M.-M., Q. Yang, J. Zhang, S.-M. Liu, Y. Zhang, H. Lin, Z.-F. Huang, Y.-Y. Wang, X.-D. Zhang, B. Zhong, and H.-B. Shu. 2014. TRIM38 inhibits TNFα- and IL-1β–triggered NF-κB activation by mediating lysosome-dependent degradation of TAB2/3. Proceedings of the National Academy of Sciences 111: 1509–1514.

30.

Shibata, M., T. Sato, R. Nukiwa, T. Ariga, and S. Hatakeyama. 2012. TRIM45 negatively regulates NF-kappaB-mediated transcription and suppresses cell proliferation. Biochemical and Biophysical Research Communications 423: 104–109.PubMed

31.

Hao, M.Q., L.J. Xie, W. Leng, and R.W. Xue. 2019. Trim47 is a critical regulator of cerebral ischemia-reperfusion injury through regulating apoptosis and inflammation. Biochemical and Biophysical Research Communications 515: 651–657.PubMed

32.

Bai, X., Y.-L. Zhang, and L.-N. Liu. 2020. Inhibition of TRIM8 restrains ischaemia-reperfusion-mediated cerebral injury by regulation of NF-κB activation associated inflammation and apoptosis. Experimental Cell Research 388: 111818.PubMed

33.

Muskardin, T.L.W., and T.B. Niewold. 2018. Type I interferon in rheumatic diseases. Nature Reviews Rheumatology 14: 214–228.PubMedPubMedCentral

34.

Higgs, R., J. Ní Gabhann, N. Ben Larbi, E.P. Breen, K.A. Fitzgerald, and C.A. Jefferies. 2008. The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3. Journal of Immunology (Baltimore, Md. : 1950) 181: 1780–1786.

35.

Tan, T., and L. Xia. 2020. TRIM21 Aggravates herpes simplex virus epithelial keratitis by attenuating STING-IRF3-mediated type I interferon signaling. Frontiers in Microbiology 11: 703–703.PubMedPubMedCentral

36.

Stacey, K.B., E. Breen, and C.A. Jefferies. 2012. Tyrosine phosphorylation of the E3 ubiquitin ligase TRIM21 positively regulates interaction with IRF3 and hence TRIM21 activity. PLoS One 7: e34041.PubMedPubMedCentral

37.

Maarifi, G., N. Smith, S. Maillet, O. Moncorgé, C. Chamontin, J. Edouard, F. Sohm, F.P. Blanchet, J.-P. Herbeuval, G. Lutfalla, et al. 2019. TRIM8 is required for virus-induced IFN response in human plasmacytoid dendritic cells. Science Advances 5: eaax3511.PubMedPubMedCentral

38.

Wu, M., C. Dan, J.F. Gui, and Y.B. Zhang. 2019. Fish species-specific TRIM gene FTRCA1 negatively regulates interferon response through attenuating IRF7 transcription. Fish & Shellfish Immunology 90: 180–187.

39.

Kondo, T., M. Watanabe, and S. Hatakeyama. 2012. TRIM59 interacts with ECSIT and negatively regulates NF-kappaB and IRF-3/7-mediated signal pathways. Biochemical and Biophysical Research Communications 422: 501–507.PubMed

40.

Zhao, W., L. Wang, M. Zhang, P. Wang, C. Yuan, J. Qi, H. Meng, and C. Gao. 2012. Tripartite motif-containing protein 38 negatively regulates TLR3/4- and RIG-I-mediated IFN-beta production and antiviral response by targeting NAP1. Journal of Immunology 188: 5311–5318.

41.

Hu, M.M., X.Q. Xie, Q. Yang, C.Y. Liao, W. Ye, H. Lin, and H.B. Shu. 2015. TRIM38 negatively regulates TLR3/4-mediated innate immune and inflammatory responses by two sequential and distinct mechanisms. Journal of Immunology 195: 4415–4425.

42.

Xue, Q., Z. Zhou, X. Lei, X. Liu, B. He, J. Wang, and T. Hung. 2012. TRIM38 negatively regulates TLR3-mediated IFN-beta signaling by targeting TRIF for degradation. PLoS One 7: e46825.PubMedPubMedCentral

43.

Bhaumik, S., and R. Basu. 2017. Cellular and molecular dynamics of Th17 differentiation and its developmental plasticity in the intestinal immune response. Frontiers in Immunology 8: 254–254.PubMedPubMedCentral

44.

Kotschenreuther, K., I. Waqué, S. Yan, A. Meyer, T. Haak, J. von Tresckow, J. Schiller, L. Gloyer, M. Dittrich-Salamon, and D.M. Kofler. 2020. Cannabinoids drive Th17 cell differentiation in patients with rheumatic autoimmune diseases. Cellular & Molecular Immunology. https://doi.org/10.1038/s41423-020-0437-4.CrossRef

45.

Espinosa, A., V. Dardalhon, S. Brauner, A. Ambrosi, R. Higgs, F.J. Quintana, M. Sjöstrand, M.-L. Eloranta, J. Ní Gabhann, O. Winqvist, B. Sundelin, C.A. Jefferies, B. Rozell, V.K. Kuchroo, and M. Wahren-Herlenius. 2009. Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. The Journal of Experimental Medicine 206: 1661–1671.PubMedPubMedCentral

46.

Brauner, S., X. Jiang, G.E. Thorlacius, A.M. Lundberg, T. Östberg, Z.-Q. Yan, V.K. Kuchroo, G.K. Hansson, and M. Wahren-Herlenius. 2017. Augmented Th17 differentiation in Trim21 deficiency promotes a stable phenotype of atherosclerotic plaques with high collagen content. Cardiovascular Research 114: 158–167.

47.

Zhou, G., W. Wu, L. Yu, T. Yu, W. Yang, P. Wang, X. Zhang, Y. Cong, and Z. Liu. 2018. Tripartite motif-containing (TRIM) 21 negatively regulates intestinal mucosal inflammation through inhibiting TH1/TH17 cell differentiation in patients with inflammatory bowel diseases. Journal of Allergy and Clinical Immunology 142: 1218–1228.e1212.

48.

Ahn, Y., J.-H. Hwang, Z. Zheng, D. Bang, and D.-Y. Kim. 2017. Enhancement of Th1/Th17 inflammation by TRIM21 in Behçet's disease. Scientific Reports 7: 3018–3018.PubMedPubMedCentral

49.

Perez-Lloret, J., I.S. Okoye, R. Guidi, Y. Kannan, S.M. Coomes, S. Czieso, G. Mengus, I. Davidson, and M.S. Wilson. 2016. T-cell-intrinsic Tif1α/Trim24 regulates IL-1R expression on TH2 cells and TH2 cell-mediated airway allergy. Proceedings of the National Academy of Sciences of the United States of America 113: E568–E576.PubMedPubMedCentral

50.

Yang, L., L. Jin, Y. Ke, X. Fan, T. Zhang, C. Zhang, H. Bian, and G. Wang. 2018. E3 Ligase Trim21 ubiquitylates and stabilizes keratin 17 to induce STAT3 activation in psoriasis. The Journal of Investigative Dermatology 138: 2568–2577.PubMed

51.

Vinter, H., A. Langkilde, V. Ottosson, A. Espinosa, M. Wahren-Herlenius, L. Raaby, C. Johansen, and L. Iversen. 2017. TRIM21 is important in the early phase of inflammation in the imiquimod-induced psoriasis-like skin inflammation mouse model. Experimental Dermatology 26: 713–720.PubMed

52.

Liu, Y., J.P. Lagowski, S. Gao, J.H. Raymond, C.R. White, and M.F. Kulesz-Martin. 2010. Regulation of the psoriatic chemokine CCL20 by E3 ligases Trim32 and Piasy in keratinocytes. The Journal of Investigative Dermatology 130: 1384–1390.PubMedPubMedCentral

53.

Liu, Y., Z. Wang, R. De La Torre, A. Barling, T. Tsujikawa, N. Hornick, J. Hanifin, E. Simpson, Y. Wang, E. Swanzey, et al. 2017. Trim32 deficiency enhances Th2 immunity and predisposes to features of atopic dermatitis. The Journal of Investigative Dermatology 137: 359–366.PubMed

54.

Espinosa, A., W. Zhou, M. Ek, M. Hedlund, S. Brauner, K. Popovic, L. Horvath, T. Wallerskog, M. Oukka, F. Nyberg, V.K. Kuchroo, and M. Wahren-Herlenius. 2006. The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death. Journal of Immunology 176: 6277–6285.

55.

Smith, S., J. Ni Gabhann, E. McCarthy, B. Coffey, R. Mahony, J.C. Byrne, K. Stacey, E. Ball, A. Bell, G. Cunnane, et al. 2014. Estrogen receptor alpha regulates tripartite motif-containing protein 21 expression, contributing to dysregulated cytokine production in systemic lupus erythematosus. Arthritis & Rhematology 66: 163–172.

56.

Kurata, R., H. Nakaoka, A. Tajima, K. Hosomichi, T. Shiina, A. Meguro, N. Mizuki, S. Ohono, I. Inoue, and H. Inoko. 2010. TRIM39 and RNF39 are associated with Behcet's disease independently of HLA-B *51 and -A *26. Biochemical and Biophysical Research Communications 401: 533–537.PubMed

57.

Hu, M.-M., and H.-B. Shu. 2017. Multifaceted roles of TRIM38 in innate immune and inflammatory responses. Cellular & Molecular Immunology 14: 331–338.

Titel: TRIM Proteins in Inflammation: from Expression to Emerging Regulatory Mechanisms
verfasst von: Luting Yang
Haibin Xia
Publikationsdatum: 07.01.2021
Verlag: Springer US
Erschienen in: Inflammation / Ausgabe 3/2021
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI: https://doi.org/10.1007/s10753-020-01394-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

CKD bei Diabetes: Neuheiten und Zukunftsaussichten

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Jeder Mensch mit Diabetes muss auf eine chronische Nierenerkrankung gescreent werden – diese neue Empfehlung spricht die KDIGO aus. Die Therapie erfolgt individuell und je nach Szenario mit verschiedenen Substanzklassen. Künftig kommt wahrscheinlich, neben RAS-Hemmung, SGLT2-Inhibition und nsMRA, eine vierte Therapiesäule hinzu.

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

SGLT2-Inhibitoren und GLP-1-Rezeptoragonisten im Schlagabtausch

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Wer hat die Nase vorn – SGLT2-Inhibitoren oder GLP-1-Rezeptoragonisten? Diese Frage diskutierten zwei Experten in einer Session auf dem diesjährigen Diabetes-Kongress.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2021

Progesterone Attenuates Brain Inflammatory Response and Inflammation-Induced Increase in Immature Myeloid Cells in a Mouse Model

Mitigation of Gliadin-Induced Inflammation and Cellular Damage by Curcumin in Human Intestinal Cell Lines

Correction to: WISP1 and TLR4 on Macrophages Contribute to Ventilator-Induced Lung Injury

Correction to: Inhibition of C3a/C3aR Axis in Diverse Stages of Ulcerative Colitis Affected the Prognosis of UC by Modulating the Pyroptosis and Expression of Caspase-11

Focal Adhesion Kinase Activity and Localization is Critical for TNF-α-Induced Nuclear Factor-κB Activation